ATXI (ATXI) Stock Price & Analysis
ATXI (ATXI) fell 4.48% to USD 0.54 as of September 8, 2026 at 06:55 UTC, according to Nexqual real-time market data.
ATXI last closed at USD 0.54; the session ranged USD 0.52–0.52 on volume of 2,555 shares. Market capitalization is —, with a 52-week range of USD 0.15–0.97 (OID). Source: Nexqual, September 8, 2026 at 06:55 UTC.
Key Statistics (as of September 8, 2026 at 06:55 UTC)
| Price | USD 0.54 |
|---|---|
| Change | ▼ 4.48% (down) |
| Previous Close | USD 0.54 |
| Open | USD 0.54 |
| Day Range | USD 0.52 – 0.52 |
| 52-Week Range | USD 0.15 – 0.97 |
| Volume | 2,555 shares |
| Market Cap | — |
| Exchange | OID |
Technical Analysis (ATXI)
Nexqual's technical model rates ATXI "BUY" based on 5 bullish and 1 bearish signals across 128 daily candles, as of September 8, 2026 at 06:55 UTC.
| Overall Signal | BUY |
|---|---|
| RSI (14) | 68.02 (neutral) |
| vs SMA50 | Above (USD 0.33) |
| MACD | 0.07 (positive) |
From ATXI's Latest SEC 10-K Filing (filed 2026-03-30)
Source: SEC EDGAR 10-K. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| ARDS | Aridis Pharmaceuticals Inc. | USD 0 | ▲ 0% |
| KPRX | Kiora Pharmaceuticals, Inc. | USD 2.55 | ▼ 1.54% |
| ADTX | Aditxt, Inc. | USD 0.01 | ▲ 0% |
| PALI | Palisade Bio, Inc. | USD 2.09 | ▲ 5.03% |
| ENSC | Ensysce Biosciences, Inc. | USD 0.46 | ▲ 2.93% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: September 8, 2026 at 06:55 UTC. This page is informational and not investment advice.